BCAP29 Antikörper (Middle Region)
Kurzübersicht für BCAP29 Antikörper (Middle Region) (ABIN636123)
Target
Alle BCAP29 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- BCAP29 antibody was raised against the middle region of BCAP29
-
Aufreinigung
- Affinity purified
-
Immunogen
- BCAP29 antibody was raised using the middle region of BCAP29 corresponding to a region with amino acids GVMEPQQRNADSHQKLEEAKNRFFPRASSSRSMALQIPIKLILDFLASRT
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
BCAP29 Blocking Peptide, (ABIN939030), is also available for use as a blocking control in assays to test for specificity of this BCAP29 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCAP29 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BCAP29 (B-Cell Receptor-Associated Protein 29 (BCAP29))
-
Andere Bezeichnung
- BCAP29
-
Hintergrund
- BCAP29 may play a role in anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi. BCAP29 may be involved in CASP8-mediated apoptosis.
-
Molekulargewicht
- 39 kDa (MW of target protein)
Target
-